<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34873584</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Disentangling post-vaccination symptoms from early COVID-19.</ArticleTitle><Pagination><StartPage>101212</StartPage><MedlinePgn>101212</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101212</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2021.101212</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Identifying and testing individuals likely to have SARS-CoV-2 is critical for infection control, including post-vaccination. Vaccination is a major public health strategy to reduce SARS-CoV-2 infection globally. Some individuals experience systemic symptoms post-vaccination, which overlap with COVID-19 symptoms. This study compared early post-vaccination symptoms in individuals who subsequently tested positive or negative for SARS-CoV-2, using data from the COVID Symptom Study (CSS) app.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a prospective observational study in 1,072,313 UK CSS participants who were asymptomatic when vaccinated with Pfizer-BioNTech mRNA vaccine (BNT162b2) or Oxford-AstraZeneca adenovirus-vectored vaccine (ChAdOx1 nCoV-19) between 8 December 2020 and 17 May 2021, who subsequently reported symptoms within seven days (N=362,770) (other than local symptoms at injection site) and were tested for SARS-CoV-2 (N=14,842), aiming to differentiate vaccination side-effects <i>per se</i> from superimposed SARS-CoV-2 infection. The post-vaccination symptoms and SARS-CoV-2 test results were contemporaneously logged by participants. Demographic and clinical information (including comorbidities) were recorded. Symptom profiles in individuals testing positive were compared with a 1:1 matched population testing negative, including using machine learning and multiple models considering UK testing criteria.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Differentiating post-vaccination side-effects alone from early COVID-19 was challenging, with a sensitivity in identification of individuals testing positive of 0.6 at best. Most of these individuals did not have fever, persistent cough, or anosmia/dysosmia, requisite symptoms for accessing UK testing; and many only had systemic symptoms commonly seen post-vaccination in individuals negative for SARS-CoV-2 (headache, myalgia, and fatigue).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Post-vaccination symptoms <i>per se</i> cannot be differentiated from COVID-19 with clinical robustness, either using symptom profiles or machine-derived models. Individuals presenting with systemic symptoms post-vaccination should be tested for SARS-CoV-2 or quarantining, to prevent community spread.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">UK Government Department of Health and Social Care,&#xa0;Wellcome&#xa0;Trust, UK Engineering and Physical Sciences Research Council, UK National Institute for Health Research, UK Medical Research Council and British Heart Foundation, Chronic Disease Research Foundation, Zoe&#xa0;Limited.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canas</LastName><ForeName>Liane S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;sterdahl</LastName><ForeName>Marc F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ZOE Limited, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selvachandran</LastName><ForeName>Somesh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ZOE Limited, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polidori</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ZOE Limited, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ZOE Limited, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molteni</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liyuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerfoot</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klaser</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammers</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London &amp; Guy's and St Thomas' PET Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spector</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ourselin</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steves</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sudre</LastName><ForeName>Carole H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Council Unit for Lifelong Health and Ageing, Department of Population Science and Experimental Medicine. UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modat</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, Kings College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20030</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20051</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AUC, Area under the curve</Keyword><Keyword MajorTopicYN="N">BMI, Body mass index</Keyword><Keyword MajorTopicYN="N">CI, Confidence interval</Keyword><Keyword MajorTopicYN="N">COVID-19 detection</Keyword><Keyword MajorTopicYN="N">COVID-19, Coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">CSS, COVID Symptoms Study</Keyword><Keyword MajorTopicYN="N">DI, Data invalid</Keyword><Keyword MajorTopicYN="N">Early detection</Keyword><Keyword MajorTopicYN="N">IQR, inter quartile range</Keyword><Keyword MajorTopicYN="N">KCL, King's College London</Keyword><Keyword MajorTopicYN="N">LFAT, Lateral flow antigen test</Keyword><Keyword MajorTopicYN="N">LR, Logistic Regression</Keyword><Keyword MajorTopicYN="N">Mobile technology</Keyword><Keyword MajorTopicYN="N">NHS UK, National Health Service of the United Kingdom</Keyword><Keyword MajorTopicYN="N">O-AZ, Oxford-AstraZeneca adenovirus-vectored vaccine</Keyword><Keyword MajorTopicYN="N">PB, Pfizer-BoiNTech mRNA vaccine</Keyword><Keyword MajorTopicYN="N">RF, Random forest</Keyword><Keyword MajorTopicYN="N">ROC, Receiver operating curve</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2, Severe acute respiratory syndrome-related coronavirus-2</Keyword><Keyword MajorTopicYN="N">Self-reported symptoms</Keyword><Keyword MajorTopicYN="N">Side-effects</Keyword><Keyword MajorTopicYN="N">UK, United Kingdom of Great Britain and Nothern Ireland</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword><Keyword MajorTopicYN="N">bMEM, Bayesian mixed-effect model</Keyword><Keyword MajorTopicYN="N">rtPCR, Reverse transcription polymerase chain reaction</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome&#x2010;related coronavirus 2 (SARS-CoV-2)</Keyword></KeywordList><CoiStatement>CJS report grants from the Chronic Disease Research Foundation (CDRF), Medical Research Council (MRC) and Wellcome Trust during the conduct of the study. ELD reports being a co-lead of the KCL COVID Symptom Study Biobank, a research-supported biobank of individuals with Long COVID, administered through King's College London, during this study.EM reports grants from the MRC, as a personal fellowship. CHS reports grant from Alzheimer's Society. CH, SS, LP, AM report other from ZOE Limited and are employed by ZOE Limited, during the conduct of the study. TS is a scientific advisor to ZOE Limited. CHS reports grants from Alzheimer's Society, during the conduct of the study. SO reports grants from the Wellcome Trust, Innovate UK (UKRI), and Chronic Disease Research Foundation (CDRF), during the conduct of the study. All the other authors have no conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34873584</ArticleId><ArticleId IdType="pmc">PMC8635464</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2021.101212</ArticleId><ArticleId IdType="pii">S2589-5370(21)00493-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometer  COVID-19 Coronavirus Pandemic. Oct 13, 2020 https://www.worldometers.info/coronavirus/ accessed.</Citation></Reference><Reference><Citation>World Health Organisation WHO Coronavirus (COVID-19) Dashboard. 2021 published online May 25.</Citation></Reference><Reference><Citation>Medicines and Healthcare products Regulatory Agency  Public Assessment Report Authorisation for Temporary Supply COVID-19 mRNA Vaccine BNT162b2 (BNT162b2 RNA) concentrate for solution for injection. May 26, 2021 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/944544/COVID-19_mRNA_Vaccine_BNT162b2__UKPAR___PFIZER_BIONTECH__15Dec2020.pdf accessed.</Citation></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine. 2020;383:2603&#x2013;2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. The Lancet. 2020;396:467&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445431</ArticleId><ArticleId IdType="pubmed">32702298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet. 2020;396:1979&#x2013;1993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674972</ArticleId><ArticleId IdType="pubmed">33220855</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicines and Healthcare products Regulatory Agency  Public Assessment Report Authorisation for Temporary Supply COVID-19 Vaccine AstraZeneca, solution for injection in multidose container COVID-19 Vaccine (ChAdOx1-S [recombinant]) Department of Health and Social Care (DHSC) AstraZeneca AB. May 26, 2021 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/963928/UKPAR_COVID_19_Vaccine_AstraZeneca_23.02.2021.pdf accessed.</Citation></Reference><Reference><Citation>Baden LR, el Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine. 2021;384:403&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicines and Healthcare products Regulatory Agency  Public Assessment Report National Procedure COVID-19 Vaccine Moderna. 0.20 mg/mL dispersion for injection (COVID-19 mRNA Vaccine [nucleoside modified]) May 26, 2021 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977367/UKPAR_COVID_19_Vaccine_Moderna_07.04.2021_CMA_Reliance_PAR__-__final.pdf accessed.</Citation></Reference><Reference><Citation>Sadoff J, Gray G, Vandebosch A, et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. New England Journal of Medicine. 2021;384:2187&#x2013;2201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220996</ArticleId><ArticleId IdType="pubmed">33882225</ArticleId></ArticleIdList></Reference><Reference><Citation>British Broadcasting Corporation . Vol. 8. BBC News; 2020. (Covid-19 vaccine: First person receives Pfizer jab in UK). published online Dec.</Citation></Reference><Reference><Citation>Department of Health and Social Care Press Release: First people to receive Oxford University. DHSC. 2021 Press Release: First people to receive Oxford University/AstraZeneca COVID-19 vaccine today. published online Jan 4.</Citation></Reference><Reference><Citation>Government of the United Kingdom  Coronavirus (COVID-19) in the UK - Cases by specimen date. GOV UK. 2021 https://coronavirus.data.gov.uk/details/cases published online Jan 29. accessed May 26, 2021.</Citation></Reference><Reference><Citation>Drew DA, Nguyen LH, Steves CJ, et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020;368:1362&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200009</ArticleId><ArticleId IdType="pubmed">32371477</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nature Medicine. 2020;26:1037&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. The Lancet Infectious Diseases. 2021 doi: 10.1016/S1473-3099(21)00224-3. published online May 20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00224-3</ArticleId><ArticleId IdType="pmc">PMC8078878</ArticleId><ArticleId IdType="pubmed">33930320</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicines &amp; Healthcare products Regulatory Agency  Coronavirus vaccine - weekly summary of Yellow Card reporting. 2021 https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting London:MHRApublished online May 26. accessed June 9, 2021.</Citation></Reference><Reference><Citation>Schultz NH, S&#xf8;rvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. New England Journal of Medicine. 2021 doi: 10.1056/nejmoa2104882. published online April 9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2104882</ArticleId><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. New England Journal of Medicine. 2021 doi: 10.1056/nejmoa2104840. published online April 9. DOI.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2104840</ArticleId><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyf T, Deeks JJ, Dinnes J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. The Cochrane database of systematic reviews. 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386785</ArticleId><ArticleId IdType="pubmed">32633856</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas LS, Sudre CH, Capdevila Pujol J, et al. Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study. The Lancet Digital Health. 2021;3:e587&#x2013;e598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8321433</ArticleId><ArticleId IdType="pubmed">34334333</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks Jackson J, Dempewolf S, Johnson AL, van Ert H, Maury W. Dynamics of Humoral Immunity Post COVID Vaccination &#x2013; A Case Report. Clin Rev &amp; Cases. 2021;3:1&#x2013;2.</Citation></Reference><Reference><Citation>Watson J, Richter A, Deeks J. Testing for SARS-CoV-2 antibodies. The BMJ. 2020;370 doi: 10.1136/bmj.m3325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3325</ArticleId><ArticleId IdType="pubmed">32900692</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS UK  Coronavirus (COVID-19) 2020 https://www.nhs.uk/conditions/coronavirus-covid-19/ published online Nov 1. (accessed Feb 2, 2021)</Citation></Reference><Reference><Citation>Rai B, Shukla A, Dwivedi LK. Estimates of serial interval for COVID-19: A systematic review and meta-analysis. Clinical epidemiology and global health. 2021;9:157&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448781</ArticleId><ArticleId IdType="pubmed">32869006</ArticleId></ArticleIdList></Reference><Reference><Citation>McAloon C, Collins &#xc1;, Hunt K, et al. Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ open. 2020;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7430485</ArticleId><ArticleId IdType="pubmed">32801208</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Keshet A, Graham MS, et al. Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study. medRxiv. 2020 2020.12.15.20248096.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez Alberto, Garc&#xed;a Salvador, Galar Mikel, Prati Ronaldo C., Krawczyk Bartosz, Herrera Francisco. Springer; Cham: 2018. Learning from Imbalanced Data Sets.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-98074-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulesa A, Krzywinski M, Blainey P, Altman N. Points of Significance: Sampling distributions and the bootstrap. Nature Methods. 2015;12:477&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4737599</ArticleId><ArticleId IdType="pubmed">26221652</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Small DS. The use of bootstrapping when using propensity-score matching without replacement: a simulation study. Statistics in medicine. 2014;33:4306&#x2013;4319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4260115</ArticleId><ArticleId IdType="pubmed">25087884</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study. medRxiv. 2021 2021.05.24.21257738.</Citation><ArticleIdList><ArticleId IdType="pubmed">37777159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop Christopher M. Pattern Recognition and Machine Learning. 2006 doi: 10.1198/tech.2007.s518. New York.</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/tech.2007.s518</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham M, May A, Varsavsky T, et al. Knowledge barriers in the symptomatic-COVID-19 testing programme in the UK: an observational study. 2021 doi: 10.1101/2021.03.16.21253719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.16.21253719</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency  What to expect after your COVID-19 vaccination. 2021 https://www.gov.uk/government/publications/covid-19-vaccination-what-to-expect-after-vaccination/what-to-expect-after-your-covid-19-vaccination published online Oct 6.</Citation></Reference><Reference><Citation>Wells PM, Doores KJ, Couvreur S, et al. Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England. Journal of Infection. 2020;81:931&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557299</ArticleId><ArticleId IdType="pubmed">33068628</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health England. Green Book. In: COVID-19-SARS-CoV-2 Notifiable. 2021 https://fingertips.phe.org.uk/static-reports/mortality-surveillance/excess-mortality-in</Citation></Reference><Reference><Citation>Harada S, Uno S, Ando T, et al. Control of a Nosocomial Outbreak of COVID-19 in a University Hospital. Open Forum Infectious Diseases. 2020;7:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665726</ArticleId><ArticleId IdType="pubmed">33330740</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter B, Collins JT, Barlow-Pay F, et al. Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople) Journal of Hospital Infection. 2020;106:376&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372282</ArticleId><ArticleId IdType="pubmed">32702463</ArticleId></ArticleIdList></Reference><Reference><Citation>Houlihan CF, Vora N, Byrne T, et al. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. The Lancet. 2020;396:e6&#x2013;e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347344</ArticleId><ArticleId IdType="pubmed">32653078</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook TM, El-Boghdadly K, Brown J, Pickering AE. The safety of anaesthetists and intensivists during the first COVID-19 surge supports extension of use of airborne protection PPE to ward staff. Clinical Medicine, Journal of the Royal College of Physicians of London. 2021;21:E137&#x2013;E139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8002765</ArticleId><ArticleId IdType="pubmed">33509933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall VJ, Foulkes S, Saei A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. The Lancet. 2021;397:1725&#x2013;1735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064668</ArticleId><ArticleId IdType="pubmed">33901423</ArticleId></ArticleIdList></Reference><Reference><Citation>Angel Y, Spitzer A, Henig O, et al. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers. JAMA. 2021 doi: 10.1001/jama.2021.7152. published online May 6. DOI.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7152</ArticleId><ArticleId IdType="pmc">PMC8220476</ArticleId><ArticleId IdType="pubmed">33956048</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. The Lancet. 2021;397:1819&#x2013;1829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099315</ArticleId><ArticleId IdType="pubmed">33964222</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailly B, Guilpain L, Bouiller K, et al. BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity. Clinical Infectious Diseases. 2021 doi: 10.1093/cid/ciab446. published online May 16DOI.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab446</ArticleId><ArticleId IdType="pmc">PMC8241482</ArticleId><ArticleId IdType="pubmed">33993228</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaqout A, Daghfal J, Alaqad I, et al. The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout. International Journal of Infectious Diseases. 2021;108:116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117665</ArticleId><ArticleId IdType="pubmed">33992763</ArticleId></ArticleIdList></Reference><Reference><Citation>Angel R, Thoits P. The impact of culture on the cognitive structure of illness. Cult Med Psychiatry. 1987;4:465&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">3319427</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiber C, Shattuck EC, Fiore S, Alperin P, Davis V, Moore J. Change in Human Social Behavior in Response to a Common Vaccine. Annals of Epidemiology. 2010;20:729&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">20816312</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer NT, Cuite CL, Herrington JE, Weinstein ND. Risk compensation and vaccination: Can getting vaccinated cause people to engage in risky behaviors? Annals of Behavioral Medicine. 2007;34:95&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">17688401</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber W, Lammel O, Siebenhofer A, Redlberger-Fritz M, Panovska-Griffiths J, Czypionka T. Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2) EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8277224</ArticleId><ArticleId IdType="pubmed">34278276</ArticleId></ArticleIdList></Reference><Reference><Citation>Fert&#xe9; T, Ramel V, Cazanave C, et al. Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study. Journal of Clinical Virology. 2021;141</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8178956</ArticleId><ArticleId IdType="pubmed">34134035</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>